Supplementation (typically 500-2000 mg daily) can boost its effects
Increasing aspirin to 150 mg daily produced modest benefit, and misoprostol was discontinued as a result of abdominal cramping
Plaintiffs claim manufacturers: Knew or should have known gastroparesis could be permanent Failed to adequately warn patients and doctors Understated the severity and duration of risk Continued aggressive marketing despite safety signals 2
Rank N, Michel C, Haertel C, et al
Personalized dietary advice could help patients set realistic expectations about their outcomes, as GLP-1 medications are not cure-alls, and significant lifestyle changes may be beneficial
The most frequent are gastrointestinal issues like nausea, vomiting, or constipation